味の素株式会社 · FY2026

Is Ajinomoto really a seasoning company?

Think Ajinomoto and the first image is still umami seasoning. And in FY2026, roughly three-quarters of sales did come from seasonings, foods and frozen foods. Yet the same group also supplies pharmaceutical ingredients and culture media, provides drug-development and manufacturing services, and makes insulating film used inside semiconductor packages for AI servers.

77.5%Sales from seasonings & foods plus frozen foods
¥66.2bnBusiness profit from Healthcare and Others
95%+ABF market share maintained since launch

This is not investment advice or a stock recommendation. We reorder company-published primary-source facts to make the shape of the business easier to see.

The company name itself is inseparable from one product in many people’s minds: AJI-NO-MOTO® umami seasoning.

That makes “seasoning company” a natural first impression. And current numbers do not make that impression wrong.

What changes the picture is how far the company has traveled from that starting point.

First, sales are ¥1.584 trillion

The total is large, but the mix tells us how accurate the familiar food-company image still is.

77.5% of sales still comes from food

DATA VIEW

Roughly three-quarters of sales is still food

FY2026. Site calculation combining Seasonings and Foods with Frozen Foods.

Sales mix: Food 77.5%, Non-food 22.5%Sales mix
Food77.5%Non-food22.5%

The interesting part is that the story does not end there.

Healthcare and Others alone generates ¥341.5 billion

Its presence becomes even larger when viewed through profit rather than sales.

Business profit was ¥66.2 billion—up about 45%

DATA VIEW

Its profit presence is larger than its sales share

FY2026. Business profit figures exclude shared companywide expenses.

¥936.9bnSeasonings & Foods sales
¥341.5bnHealthcare & Others sales
¥66.2bnHealthcare & Others business profit

Why does a seasoning company have businesses like these in the first place?

Amino-acid research expanded into pharmaceuticals

That path is relatively intuitive: amino acids used in food can also matter in nutrition and healthcare.

The second path is much less obvious.

The semiconductor-material lineage also starts in AJI-NO-MOTO® production

Seasoning and semiconductor packaging serve completely different customers in completely different places.

But the business history shows continuity in reusing materials, deepening synthesis know-how, and learning how to formulate materials for new functions.

ABF has maintained more than 95% share since launch

The share figure is striking on its own. What the material actually does changes the company image even more.

It sits under CPUs, GPUs and ASICs

Ajinomoto materials therefore appear inside computers in places a grocery-store view of the company would never reveal.

And AI is changing how much of that material can be required.

AI packages are becoming larger and more layered

The point is not to relabel Ajinomoto as a semiconductor company.

Food still accounts for 77.5% of FY2026 sales. It remains the center of the group.

But fermentation, chemical synthesis, formulation and materials development built around that center have repeatedly created businesses outside food.

THE VIEW AFTER THE NUMBERS

What the numbers suggest

Connect the numbers and Ajinomoto looks less like a company that stopped being a seasoning maker and more like one that has carried technologies born around food unusually far into other fields.

Roughly three-quarters of sales is still food. At the same time, Healthcare and Others generates ¥341.5 billion of sales and ¥66.2 billion of business profit. Amino-acid research expanded into pharmaceuticals and culture media, while a functional-materials lineage that began with a byproduct of AJI-NO-MOTO® production eventually produced ABF, a semiconductor material that Ajinomoto says has maintained more than 95% market share since launch.

Food, medicine and AI semiconductors look like separate businesses when placed side by side. Read the primary sources chronologically, though, and Ajinomoto starts to look less defined by a single product category and more by the habit of extending one body of technology into the next use case.

Primary sources used

Growth Strategy for the Electronic Materials Business

Ajinomoto Co., Inc. · 2026-06-30

Pages used: p.3 / p.9 / p.11

Open source →

NEXT COMPANY

ヤマハ株式会社 · FY2026

Look at the next company

Is Yamaha really a company that sells musical instruments?

Yamaha is not moving away from being an instrument maker. It is extending the sound technologies and musician relationships built through instruments into spaces, cars, software, and ongoing services.

See the company through the numbers →
30.6%Revenue from audio equipment